SOL Capital Management’s Sanofi SNY Stock Holding History

SOL Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-6,100	Closed	-$304K	–	251
2017 Q3	$304K	Hold	6,100	–	–	0.09%	205
2017 Q2	$292K	Hold	6,100	–	–	0.08%	206
2017 Q1	$276K	Sell	6,100 -200	-3%	-$8.48K	0.08%	201
2016 Q4	$255K	Hold	6,300	–	–	0.08%	205
2016 Q3	$241K	Hold	6,300	–	–	0.08%	194
2016 Q2	$264K	Sell	6,300 -100	-2%	-$4.1K	0.09%	175
2016 Q1	$257K	Sell	6,400 -150	-2%	-$6.03K	0.09%	178
2015 Q4	$279K	Hold	6,550	–	–	0.1%	170
2015 Q3	$311K	Sell	6,550 -115	-2%	-$5.86K	0.12%	149
2015 Q2	$330K	Hold	6,665	–	–	0.12%	151
2015 Q1	$330K	Hold	6,665	–	–	0.12%	147
2014 Q4	$304K	Hold	6,665	–	–	0.12%	149
2014 Q3	$376K	Hold	6,665	–	–	0.16%	123
2014 Q2	$354K	Hold	6,665	–	–	0.14%	131
2014 Q1	$348K	Hold	6,665	–	–	0.14%	129
2013 Q4	$357K	Hold	6,665	–	–	0.14%	128
2013 Q3	$337K	Buy	6,665 +315	+5%	+$16K	0.14%	131
2013 Q2	$327K	Buy	+6,350	New	+$338K	0.13%	131

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SOL Capital Management's SNY Position: Q4 2017 in Review

SOL Capital Management sold out of Sanofi (SNY) in Q4 2017, closing a stake of 6,100 shares — an estimated $304K sold.

SOL Capital Management first reported a position in SNY in Q2 2013 and held it in 18 quarters. The position peaked at $376K in Q3 2014. 504 funds tracked by Wall St. Rank hold SNY as of Q4 2017.

SOL Capital Management reported no remaining Sanofi position as of Q4 2017 after selling out during the quarter.
SOL Capital Management sold 6,100 Sanofi shares in Q4 2017, an estimated $304K.
SOL Capital Management first reported a position in Sanofi in Q2 2013 and held it in 18 quarters.
SOL Capital Management's Sanofi position peaked at $376K in Q3 2014.
504 funds tracked by Wall St. Rank held Sanofi as of Q4 2017.

Based on SOL Capital Management's 13F filing for Q4 2017, filed 31 Jan 2018.